Drug recall · November 17, 2021
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 50 INJ INJECTABLE recall
Why: Lack of assurance of sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 50 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Lots / codes
Lot: 07082021:16 BUD: 10/23/2021; 08172021:26 BUD: 02/08/2022
- Quantity
- 4 vials
- Company
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy, San Antonio, TX
- Distribution
- United States including Washington, D.C. and Puerto Rico
- Initiated
- October 12, 2021 · Voluntary: Firm initiated
- Classified
- November 8, 2021
- Reported
- November 17, 2021
- Ended
- October 4, 2023
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Papaverine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.